Prospective Observational Epidemiologic Study of Maraviroc's Safety
- Conditions
- Human Immunodeficiency Virus
- Interventions
- Drug: Optimized background antiretroviral drug regimen without maraviroc
- Registration Number
- NCT00665561
- Lead Sponsor
- ViiV Healthcare
- Brief Summary
The study will assess if use of maraviroc along with an optimized background regimen of antiretroviral drugs in usual clinical practice is as safe as using only an optimized regimen of antiretroviral drugs.
- Detailed Description
All patients meeting the study eligibility criteria at participating sites will be invited to participate.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2500
- Treatment experienced, HIV-1 infected patients
- 18 years or older
- Receive an approved assay for determination of HIV-1 tropism
- Pregnant or lactating
- Using CCR5 inhibitor other than maraviroc
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Maraviroc exposed Maraviroc along with an optimized background antiretroviral drug regimen - Maraviroc unexposed Optimized background antiretroviral drug regimen without maraviroc -
- Primary Outcome Measures
Name Time Method Density Rate Per 1000 Participant-Years for Incidence of Viral Encephalitis Up to 5 years following enrollment Density rate per 1000 participant-years for incidence of viral encephalitis was reported. Density rate was calculated as the number of events (n) per 1000 participant-years at risk. Poisson regressions were fit to the categorical events with only treatment in the model to obtain the crude rate and CI.
Density Rate Per 1000 Participant-Years for Incidence of Death Due to Any Cause Up to 5 years following enrollment Density rate per 1000 participant-years for incidence of death due to any cause was reported. Density rate was calculated as the number of events (n) per 1000 participant-years at risk. Poisson regressions were fit to the categorical events with only treatment in the model to obtain the crude rate and CI.
Adjusted Density Rate Per 1000 Participant-Years for Incidence of Centers for Disease Control and Prevention Category C Aids-Defining Opportunistic Infections Up to 5 years following enrollment Adjusted density rate per 1000 participant-years for incidence of centers for disease control and prevention category c aids-defining opportunistic infections was reported. Density rate was calculated as the number of events (n) per 1000 participant-years at risk. Poisson regressions were fit to the categorical events with treatment as the main effect, propensity score (PS) quartile and imputed Framingham score (FS) as covariates in the model to obtain the adjusted rate and CI.
Percentage of Participants With All-Cause Mortality Up to 5 years following enrollment All-cause death was defined as the death due to any cause during the course of study.
Density Rate Per 1000 Participant-Years for Incidence of Centers for Disease Control and Prevention Category C AIDS -Defining Opportunistic Infections Up to 5 years following enrollment Density rate per 1000 participant-years for incidence of centers for disease control and prevention category C acquired immunodeficiency syndrome (AIDS) -defining opportunistic infections was reported. Density rate was calculated as the number of events (n) per 1000 participant-years at risk. Poisson regressions were fit to the categorical events with only treatment in the model to obtain the crude rate and confidence interval (CI).
Density Rate Per 1000 Participant-Years for Incidence of All Malignancies (AIDS Defining Malignancies and Non-AIDS Defining Malignancies) Up to 5 years following enrollment Density rate per 1000 participant-years for incidence of all malignancies as well as its types (categorized as: AIDS defining malignancies and non-AIDS defining malignancies) were reported. AIDS defining malignancies included malignancies due to any of these: cervical cancer, Kaposi's sarcoma or lymphoma; whereas all other malignancies (except AIDS-defining) were non-aids defining malignancies. Density rate was calculated as the number of events (n) per 1000 participant-years at risk. Poisson regressions were fit to the categorical events with only treatment in the model to obtain the crude rate and CI.
Density Rate Per 1000 Participant-Years for Incidence of Liver Failure Up to 5 years following enrollment Density rate per 1000 participant-years for incidence of liver failure was reported. Density rate was calculated as the number of events (n) per 1000 participant-years at risk. Poisson regressions were fit to the categorical events with only treatment in the model to obtain the crude rate and CI.
Density Rate Per 1000 Participant-Years for Incidence of Myocardial Infarction or Ischemia: Events Adjudicated as 'Definite' or 'Possible' Up to 5 years following enrollment Density rate per 1000 participant-years for incidence of myocardial infarction or ischemia (definite + possible) was reported. Events of myocardial infarction or ischemia were adjudicated as definite or possible; where definite= an event had definitely occurred; possible =an event had possibly occurred. Density rate was calculated as the number of events (n) per 1000 participant-years at risk. Poisson regressions were fit to the categorical events with only treatment in the model to obtain the crude rate and CI. In this outcome measure, density rate per 1000 participant-years for incidence of myocardial infarction or ischemia (which included sum of definite + possible events) was reported.
Density Rate Per 1000 Participant-Years for Incidence of Myocardial Infarction or Ischemia: Events Adjudicated as 'Definite' or 'Possible' or 'Insufficient Data' Up to 5 years following enrollment Density rate per 1000 participant-years for incidence of myocardial infarction or ischemia (definite + possible + insufficient data) was reported. Events of myocardial infarction or ischemia were adjudicated as definite or possible or insufficient data; where definite= an event had definitely occurred; possible =an event had possibly occurred; insufficient =insufficient data to determine whether an event had occurred. Density rate was calculated as the number of events (n) per 1000 participant-years at risk. Poisson regressions were fit to the categorical events with only treatment in the model to obtain the crude rate and CI. In this outcome measure, density rate per 1000 participant-years for incidence of myocardial infarction or ischemia (which included sum of definite + possible events + insufficient data) was reported.
Density Rate Per 1000 Participant-Years for Incidence of Rhabdomyolysis Up to 5 years following enrollment Density rate per 1000 participant-years for incidence of rhabdomyolysis was reported. Density rate was calculated as the number of events (n) per 1000 participant-years at risk. Poisson regressions were fit to the categorical events with only treatment in the model to obtain the crude rate and CI.
Density Rate Per 1000 Participant-Years for Incidence of Death From Liver-Related Cause Up to 5 years following enrollment Density rate per 1000 participant-years for incidence of death from liver-related cause was reported. Density rate was calculated as the number of events (n) per 1000 participant-years at risk. Poisson regressions were fit to the categorical events with only treatment in the model to obtain the crude rate and CI.
Adjusted Density Rate Per 1000 Participant-Years for Incidence of All Malignancies (AIDS Defining Malignancies and Non-AIDS Defining Malignancies) Up to 5 years following enrollment Adjusted density rate per 1000 participant-years for incidence of all malignancies as well as its types (categorized as AIDS defining malignancies and non-AIDS defining malignancies) were reported. AIDS defining malignancies included malignancies due to any of these: cervical cancer, Kaposi's sarcoma or lymphoma; whereas all other malignancies (except AIDS-defining) were non-AIDS defining malignancies. Density rate was calculated as the number of events (n) per 1000 participant-years at risk. Poisson regressions were fit to the categorical events with treatment as the main effect, PS quartile and imputed FS as covariates in the model to obtain the adjusted rate and CI.
Adjusted Density Rate Per 1000 Participant-Years for Incidence of Myocardial Infarction or Ischemia: Events Adjudicated as 'Definite' or 'Possible' Up to 5 years following enrollment Adjusted density rate per 1000 participant-years for incidence of myocardial infarction or ischemia (definite + possible) was reported. Events of myocardial infarction or ischemia were adjudicated as definite or possible; where definite= an event had definitely occurred; possible =an event had possibly occurred. Density rate was calculated as the number of events (n) per 1000 participant-years at risk. Poisson regressions were fit to the categorical events with treatment as the main effect, PS quartile and imputed FS as covariates in the model to obtain the adjusted rate and CI. In this outcome measure, adjusted density rate per 1000 participant-years for incidence of myocardial infarction or ischemia (which included sum of definite + possible events) was reported.
Adjusted Density Rate Per 1000 Participant-Years for Incidence of Death Due to Any Cause Up to 5 years following enrollment Adjusted density rate per 1000 participant-years for incidence of death due to any cause was reported. Density rate was calculated as the number of events (n) per 1000 participant-years at risk. Poisson regressions were fit to the categorical events with treatment as the main effect, PS quartile and imputed FS as covariates in the model to obtain the adjusted rate and CI.
Adjusted Density Rate Per 1000 Participant-Years for Incidence of Myocardial Infarction or Ischemia: Events Adjudicated as 'Definite' or 'Possible' or 'Insufficient Data' Up to 5 years following enrollment Adjusted density rate per 1000 participant-years for incidence of myocardial infarction or ischemia (definite + possible + insufficient data) was reported. Events of myocardial infarction or ischemia were adjudicated as definite or possible or insufficient data; where definite= an event had definitely occurred; possible =an event had possibly occurred; insufficient =insufficient data to determine whether an event had occurred. Density rate was calculated as the number of events (n) per 1000 participant-years at risk. Poisson regressions were fit to the categorical events with treatment as the main effect, PS quartile and imputed FS as covariates in the model to obtain the adjusted rate and CI. In this outcome measure, adjusted density rate per 1000 participant-years for incidence of myocardial infarction or ischemia (which included sum of definite + possible events + insufficient data) was reported.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (265)
Providence Clinical Research
🇺🇸Burbank, California, United States
LA Gay and Lesbian Center
🇺🇸Los Angeles, California, United States
The McGregor Clinic
🇺🇸Fort Myers, Florida, United States
Health Positive
🇺🇸Safety Harbor, Florida, United States
Circle Medical, LLC
🇺🇸Norwalk, Connecticut, United States
Atlanta Primary Care
🇺🇸Atlanta, Georgia, United States
Georgia Health Sciences University
🇺🇸Augusta, Georgia, United States
Absolute Care Medical Center
🇺🇸Atlanta, Georgia, United States
Atlanta Specialty Research
🇺🇸Atlanta, Georgia, United States
WellStar Clinical Trials Office
🇺🇸Marietta, Georgia, United States
WellStar Infectious Disease
🇺🇸Marietta, Georgia, United States
Atlanta VA Medical Center
🇺🇸Decatur, Georgia, United States
Newland Medical Associates
🇺🇸Southfield, Michigan, United States
East Carolina University
🇺🇸Greenville, North Carolina, United States
Lehigh Valley Hospital
🇺🇸Allentown, Pennsylvania, United States
University of Pennsylvania
🇺🇸Philadelphia, Pennsylvania, United States
Philadelphia Fight
🇺🇸Philadelphia, Pennsylvania, United States
MCC Clinic
🇺🇸Columbia, South Carolina, United States
Southwest Infectious Disease Clinical Research, Inc.
🇺🇸Dallas, Texas, United States
UT Southwestern Medical Center HIV/AIDS Research Unit
🇺🇸Dallas, Texas, United States
Pillar Clinical Research LLC
🇺🇸Dallas, Texas, United States
Sunnybrook Health Sciences Centre
🇨🇦Toronto, Ontario, Canada
University Health Network
🇨🇦Toronto, Ontario, Canada
Care Resource
🇺🇸Miami, Florida, United States
Ruth M. Rothstein CORE Center
🇺🇸Chicago, Illinois, United States
Howard Brown Health Center
🇺🇸Chicago, Illinois, United States
University of Chicago
🇺🇸Chicago, Illinois, United States
Diversified Medical Practices, PA
🇺🇸Houston, Texas, United States
Group Health Cooperative
🇺🇸Seattle, Washington, United States
Kaiser Permanente Medical Center
🇺🇸San Francisco, California, United States
University Health Care System
🇺🇸San Antonio, Texas, United States
South Texas Veterans Health Care System
🇺🇸San Antonio, Texas, United States
Istituto Nazionale Malattie Infettive "L.Spallanzani"-IRCCS
🇮🇹Roma, Italy
Istituto Nazionale Malattie Infettive INMI- "L. Spallanzani"- I.R.C.C.S.
🇮🇹Roma, Italy
Azienda Sanitaria Locale Ospedale Civile dello Spirito Santo Presidio Ospedaliero
🇮🇹Pescara, Italy
Universita' di Roma La Sapienza, Dipartimento di Malattie Infettive e Tropicali
🇮🇹Roma, Italy
Azienda Ospedaliera San Giovanni Addolorata Presidia Santa Maria
🇮🇹Rome, Italy
Ospedale Amedeo di Savoia, Clinica Universitaria di Malattie Infettive
🇮🇹Torino, Italy
University of Oklahoma Health Sciences Center
🇺🇸Oklahoma City, Oklahoma, United States
Kaiser Permanente Northwest Region, Immune Deficiency Clinic
🇺🇸Portland, Oregon, United States
The Research and Education Group
🇺🇸Portland, Oregon, United States
Hospital Geral de Nova Iguacu
🇧🇷Nova Iguacu, RJ, Brazil
Hospital Heliopolis
🇧🇷São Paulo, SP, Brazil
Queen Elizabeth II Health Sciences Center
🇨🇦Halifax, Nova Scotia, Canada
Hopital Jean Verdier, Unite de maladies infectieuses
🇫🇷Bondy, France
Hopital Saint-andre CHU de Bordeaux
🇫🇷Bordeaux, France
Hopital de L'Hotel Dieu
🇫🇷Lyon, France
Raymond Poincare Hospital
🇫🇷Garches, France
Hopital Sainte Marguerite
🇫🇷Marseille Cedex 09, France
Cochin Hospital Saint Vincent de Paul
🇫🇷Paris Cedex 14, France
Centre Hospitalier Universitaire de Rennes
🇫🇷Rennes, France
Saint-Louis Hospital
🇫🇷Paris, France
Centre Hospitalier de Tourcoing
🇫🇷Tourcoing, France
Hopital Tenon
🇫🇷Paris, France
Office of Peter J. Ruane, MD
🇺🇸Los Angeles, California, United States
Office of Franco Antonio Felizarta MD
🇺🇸Bakersfield, California, United States
AAC/Davis Clinic
🇺🇸Huntsville, Alabama, United States
Bickerstaff Pediatric Family HIV Center
🇺🇸Long Beach, California, United States
Bipin Bhagat MD Inc.
🇺🇸Victorville, California, United States
Dupont Circle Physician's Group
🇺🇸Washington, District of Columbia, United States
Stanford ACTG
🇺🇸Palo Alto, California, United States
A Professional Corporation, Research Department
🇺🇸Palm Desert, California, United States
Monmouth Medical Center
🇺🇸Long Branch, New Jersey, United States
South Florida Infectious Deisease and Tropical Medicine Center
🇺🇸Miami, Florida, United States
University of Miami
🇺🇸Miami, Florida, United States
WellStar Kennestone Hospital
🇺🇸Marietta, Georgia, United States
Infectious Diseases Associates
🇺🇸Riverdale, Georgia, United States
St. Elizabeth's Medical Center
🇺🇸Brighton, Massachusetts, United States
Ingham County Health Department
🇺🇸Lansing, Michigan, United States
North Shore University Hospital
🇺🇸Manhasset, New York, United States
ID Associates
🇺🇸Gastonia, North Carolina, United States
Jersey Shore Medical Center
🇺🇸Neptune, New Jersey, United States
Beth Israel Medical Center
🇺🇸New York, New York, United States
St. John hospital and Medical Center
🇺🇸Grosse Pointe Woods, Michigan, United States
Beth Israel Medical Clinic
🇺🇸New York, New York, United States
Erie County Medical Center, HIV Services
🇺🇸Buffalo, New York, United States
Institute of Tropical Medicine
🇧🇪Antwerpen, Belgium
Guthrie Medical Group
🇺🇸Ithaca, New York, United States
Guthrie Clinic, Ltd.
🇺🇸Sayre, Pennsylvania, United States
University Speciality Clinics
🇺🇸Columbia, South Carolina, United States
Michael E. DeBakey Veterans Affairs Medical Center
🇺🇸Houston, Texas, United States
Dallas VA Medical Center
🇺🇸Dallas, Texas, United States
Rosedale Infectious Diseases
🇺🇸Huntersville, North Carolina, United States
Saint Hope Foundation
🇺🇸Bellaire, Texas, United States
University of Cincinnati Medical Center
🇺🇸Cincinnati, Ohio, United States
Marshall University Joan C. Edwards School of Medicine
🇺🇸Huntington, West Virginia, United States
Instituto A.Z. de Pesquisa e Ensino
🇧🇷Curitiba, Parana, Brazil
Universitair Ziekenhuis Gasthuisberg, Inwendige Geneeskunde
🇧🇪Leuven, Belgium
Hospital Dia
🇧🇷Brasilia, DF, Brazil
Clinique Medicale du Quartier Latin
🇨🇦Montreal, Quebec, Canada
Recherche Clinique Médicale des Campus
🇨🇦Quebec, Canada
Cliniques Universitaires Saint-Luc
🇧🇪Brussels, Belgium
Hopital Europeen Georges Pompidou
🇫🇷Paris, France
CH Perpignan
🇫🇷Perpignan, France
Hopital Pellegrin
🇫🇷Bordeaux, France
CHUM, Hotel-Dieu Hospital
🇨🇦Montreal, Quebec, Canada
Praxis City Ost Medizinisches Zentrum
🇩🇪Berlin, Germany
Faculdade de Medicina do ABC
🇧🇷Santo André, SP, Brazil
Arztpraxis fuer Innere Medizin Dr. Knechten
🇩🇪Aachen, Germany
Hôpital Haut - Leveque - Centre Francois Magendie
🇫🇷PESSAC Cedex, France
Ambulatorio Day Hospital Malattie Infettive
🇮🇹Bologna, Italy
Praxis Dr. Christiane Cordes
🇩🇪Berlin, Germany
Andreas Syngros Hospital
🇬🇷Athens, Greece
Tzaneion General Hospital of Piraeus
🇬🇷Piraeus, Greece
Dipartimento di Medicina Clinica Specialistica e Sperimentale
🇮🇹Bologna, Italy
Ente Ospedaliero Ospedali Galliera
🇮🇹Genova, Italy
Klinikum Dortmund
🇩🇪Dortmund, Germany
Klinik I fuer Innere Medizin der Uni-Klinik Koeln
🇩🇪Koeln, Germany
Universitaetsklinikum Carl Gustav Carus, Klinik und Poliklinik fuer Dermatologie
🇩🇪Dresden, Germany
Hospital of the J.W. Goethe University, Medical Clinic II
🇩🇪Frankfurt am Main, Germany
Busto Arsizio Hospital
🇮🇹Busto Arsizio, Italy
AOUP Paolo Giaccone, UOC Malattie Infettive
🇮🇹Palermo, Italy
Hospital General Universitário de Alicante
🇪🇸Alicante, Spain
Ludwig-Maximilians-Universitaet, Klinikum Innenstadt, Medizinische Poliklinik
🇩🇪Muenchen, Germany
University Hospital of Patras
🇬🇷Patras, Achaia, Greece
Clinica Malattie Infettive
🇮🇹Bari, Italy
Azienda Ospedaliero Universitaria Policlinico di Modena
🇮🇹Modena, Italy
Hospital Clinico San Carlos
🇪🇸Madrid, Spain
Infectomed GbR Zentrum für medizinische Studien
🇩🇪Stuttgart, Germany
Hospital Donostia
🇪🇸San Sebastian, Spain
Universita'Cattolica del Sacro Cuore Policlinico Gemelli
🇮🇹Roma, Italy
Medizinisches Versorgungszentrum
🇩🇪Muenchen, Germany
Centrum fuer interdisziplinaere Medizin Muenster GmbH
🇩🇪Muenster, Germany
SOD Malattie Infettive, La Piastra dei Servizi
🇮🇹Firenze, Italy
1 Divisione di Malattive Infettive e Servizio di Allergologia, Ospedale L. Sacco
🇮🇹Milano, Italy
Universita' degli Studi di Milano, Dipartimento di scienza clinica Luigi Sacco
🇮🇹Milano, Italy
San Raffaele Hospital
🇮🇹Milan, Italy
Azienda Ospedal Universitaria II Univ degli Studi di Napoli Servizio di Diagnosi e Terapia
🇮🇹Naples, Italy
Fondazione IRCCS Policlinico San Matteo
🇮🇹Pavia, Italy
HOPE Clinical Research
🇵🇷San Juan, Puerto Rico
Ospedale Amedeo di Savoia
🇮🇹Torino, Italy
Clinica Mutua de Terrassa
🇪🇸Terrassa, Barcelona, Spain
Complejo Hospitalario Juan Canalejo
🇪🇸A Coruña, Spain
Hospital de Tortosa Verge de La Cinta
🇪🇸Tortosa, Tarragona, Spain
Hospital San Pedro
🇪🇸Logroño, LA Rioja, Spain
Hospital Clinic I Provincial de Barcelona
🇪🇸Barcelona, Spain
Hospital Carlos Iii
🇪🇸Madrid, Spain
Hospital Universitario Germans Tias I Pujol
🇪🇸Barcelona, Spain
Unidad de Enfermedades Infecciosas
🇪🇸Cadiz, Spain
Hospital Universitario de La Princesa
🇪🇸Madrid, Spain
Hospital Universitario Reina Sofia
🇪🇸Cordoba, Spain
Hospital Universitario Virgen Del Rocio
🇪🇸Sevilla, Spain
Clinical Resource Building, Level 7
🇬🇧Newcastle upon Tyne, Newcastle, United Kingdom
Hospital Universitario de Canarias
🇪🇸Tenerife, Spain
Grahame Hayton Unit
🇬🇧London, United Kingdom
North Manchester General Hospital
🇬🇧Crumpsall, United Kingdom
Regional Infectious Diseases Unit
🇬🇧Edinburgh, United Kingdom
St. George's Hospital
🇬🇧Tooting, United Kingdom
Hull & East Yorkshire Hospitals NHS Trust
🇬🇧Cottingham, EAST Yorkshire, United Kingdom
Selly Oak Hospital
🇬🇧Birmingham, United Kingdom
Royal Victoria Infirmary
🇬🇧Newcastle upon Tyne, United Kingdom
National Jewish Health
🇺🇸Denver, Colorado, United States
Henry Ford Hospital
🇺🇸Detroit, Michigan, United States
Mayo Medical Clinic
🇺🇸Rochester, Minnesota, United States
Health Services Center
🇺🇸Hobson City, Alabama, United States
Hospital Universitario 12 de Octubre
🇪🇸Madrid, Spain
Hospital General Universitario de Elche
🇪🇸Elche, Spain
Hospital Clinico San Cecilio
🇪🇸Granada, Spain
Hospital Univ. La Paz
🇪🇸Madrid, Spain
Hospital de Mostoles
🇪🇸Madrid, Spain
Hospital Universitario Virgen de La Macarena
🇪🇸Sevilla, Spain
Complejo Hospitalario Carlos Haya
🇪🇸Malaga, Spain
Mataro Hospital
🇪🇸Mataro, Spain
Hospital Clinico Universitario
🇪🇸Valencia, Spain
Central West Clinical Research
🇺🇸Saint Louis, Missouri, United States
Universitaetsklinikum Mainz, I. Medizinische Klinik und Poliklinik,
🇩🇪Mainz, Germany
ifi-Institut am Allgemeines Krankenhaus St.Georg
🇩🇪Hamburg, Germany
Universitaetsklinikum Hamburg-Eppendorf, Ambulanzzentrum des UKE GmbH, Bereich Infektiologie
🇩🇪Hamburg, Germany
Praxis Dr. Lothar Schneider Interne Medizin, HIV Schwerpunkt
🇩🇪Fuerth, Germany
IPM - Study - Center
🇩🇪Hamburg, Germany
Mannheimer Onkologie Praxis
🇩🇪Mannheim, Germany
Gemeinschaftspraxis Untersendling
🇩🇪Muenchen, Germany
Klinikum Osnabruck
🇩🇪Osnabruck, Germany
Privatpraxis Ulmer, Frietsch, Müller
🇩🇪Stuttgart, Germany
Midtown Medical Center
🇺🇸Tampa, Florida, United States
St. Joseph's Hospital Comprehensive Research Institute
🇺🇸Tampa, Florida, United States
Tampa Care Clinic
🇺🇸Tampa, Florida, United States
Mount Sinai Beth Israel Medical Center
🇺🇸New York, New York, United States
HIV & Internal Medicine
🇺🇸New York, New York, United States
Columbia University Medical Center
🇺🇸New York, New York, United States
New York Medical College
🇺🇸Valhalla, New York, United States
Westchester Medical Center
🇺🇸Valhalla, New York, United States
Infectious Disease Research Institute, Inc
🇺🇸Tampa, Florida, United States
Hopital Pitie Salpetriere
🇫🇷Paris, France
Tarrant County Infectious Disease Assocciates
🇺🇸Fort Worth, Texas, United States
Alabama Infectious Diseases Center
🇺🇸Huntsville, Alabama, United States
Lalla-Reddy Medical Corporation
🇺🇸Fountain Valley, California, United States
Cedars Sinai Medical Group
🇺🇸Los Angeles, California, United States
University of California Irvine Medical Center
🇺🇸Orange, California, United States
Alta Bates Summit Medical Center East Bay AIDS Center
🇺🇸Oakland, California, United States
San Francisco Veterans Affairs Medical Center
🇺🇸San Francisco, California, United States
Statnford University Medical Center
🇺🇸Stanford, California, United States
Kaiser Permanente
🇺🇸Atlanta, Georgia, United States
Kaiser Permanete of Colorado Rock Creek Medical Offices
🇺🇸Lafayette, Colorado, United States
Division of Infectious Diseases, George Washington University Medical Center
🇺🇸Washington, District of Columbia, United States
Family Medical Counseling Service
🇺🇸Washington, District of Columbia, United States
George Washington University Medical Faculty Assoc
🇺🇸Washington, District of Columbia, United States
Office of Mahmoud H. Mustafa, MD, FACP
🇺🇸Washington, District of Columbia, United States
ID Consultants Inc & Infectious Disease Research Corp.
🇺🇸Boynton Beach, Florida, United States
Daniel A. Warner/Consultive Medicine
🇺🇸Daytona Beach, Florida, United States
Duval County Health Department
🇺🇸Jacksonville, Florida, United States
Associates in Infectious Disease
🇺🇸Fort Pierce, Florida, United States
Office of Albert Canas, MD
🇺🇸Miami Beach, Florida, United States
Pinellas Care Clinic
🇺🇸Saint Petersburg, Florida, United States
Rowan Tree Medical, PA
🇺🇸Wilton Manors, Florida, United States
Atlanta Infectious Disease Group
🇺🇸Atlanta, Georgia, United States
Family Health Care of Atlanta, PC
🇺🇸Atlanta, Georgia, United States
PMI Health Research Group
🇺🇸Atlanta, Georgia, United States
Chatham County Health Department
🇺🇸Savannah, Georgia, United States
Office of William Johnson, M.D.
🇺🇸Olympia Fields, Illinois, United States
Southside Health Association
🇺🇸Olympia Fields, Illinois, United States
University of Iowa Hospitals and Clinics
🇺🇸Iowa City, Iowa, United States
Southern Illinois University School of Medicine
🇺🇸Springfield, Illinois, United States
The Research Institute
🇺🇸Springfield, Massachusetts, United States
Baystate Infectious Diseases Clinical Research
🇺🇸Springfield, Massachusetts, United States
Montgomery Infectious Disease Associates, P.A. (Private Practice)
🇺🇸Silver Spring, Maryland, United States
Michigan State University College of Osteopathic Medicine
🇺🇸Lansing, Michigan, United States
Federal Medical Center Rochester
🇺🇸Rochester, Minnesota, United States
Saint Michael's Medical Center
🇺🇸Newark, New Jersey, United States
Meridian Medical Associates
🇺🇸Neptune, New Jersey, United States
CUMC Research Pharmacy
🇺🇸New York, New York, United States
Mount Sinai Downtown Comprehensive Health Program
🇺🇸New York, New York, United States
AIDS Care
🇺🇸Rochester, New York, United States
The Ohio State University Medical Center
🇺🇸Columbus, Ohio, United States
University of Toledo: Health Sciences Campus
🇺🇸Toledo, Ohio, United States
Pinnacle Health Medical Services
🇺🇸Harrisburg, Pennsylvania, United States
University of South Carolina School of Medicine
🇺🇸Columbia, South Carolina, United States
Garcias' Family Health Group
🇺🇸Harlingen, Texas, United States
Tarrant County Infectious Disease Associates
🇺🇸Fort Worth, Texas, United States
Office of Allan Rowan Kelly MD
🇺🇸Fort Worth, Texas, United States
CHU Saint Pierre
🇧🇪Brussels, Belgium
Infectious Diseases Associates of Central Virginia
🇺🇸Lynchburg, Virginia, United States
Dr. Howard Kussman, MD
🇺🇸Plano, Texas, United States
C.H.U. Sart-Tilman
🇧🇪Liege, Belgium
Centro de Referencia e Treinamento DST/AIDS
🇧🇷Sao Paulo, SP, Brazil
University of British Columbia/ Downtown Infectious Diseases Clinic
🇨🇦Vancouver, British Columbia, Canada
Clinic of Infectious and Tropical Diseases-University of Milan-San Paolo Hospital
🇮🇹Milan, Italy
Azienda Ospedaliera "Domenico Cotugno"
🇮🇹Napoli, Italy
Hospital Del Mar
🇪🇸Barcelona, Spain
Hospital Ramon Y Cajal
🇪🇸Madrid, Spain
Royal Victoria Hospital
🇬🇧Belfast, United Kingdom
Brighton and Sussex University Hospitals NHS Trust
🇬🇧Brighton, United Kingdom
Darlington Memorial Hospital
🇬🇧Darlington, United Kingdom
Royal Free Hospital, Ian Charleson Day Centre
🇬🇧London, United Kingdom
North Middlesex Hospital
🇬🇧London, United Kingdom
Warren browne Unit, Southlands Hospital
🇬🇧Shoreham-by-Sea, United Kingdom
Cobridge Community Health Centre
🇬🇧Stoke-on-Trent, United Kingdom
1st Floor St Stephens Centre
🇬🇧London, United Kingdom
Royal Victoria Infirmary Hospital
🇬🇧Newcastle Upon Tyne, United Kingdom
Ararat Research Center
🇵🇷Ponce, Puerto Rico
Valley Aids Council
🇺🇸Harlingen, Texas, United States
University of California
🇺🇸Sacramento, California, United States
Yale University School of Medicine Aids Program
🇺🇸New Haven, Connecticut, United States
Clinical AIDS & HIV
🇺🇸New Haven, Connecticut, United States
Hospital of Saint Raphael
🇺🇸New Haven, Connecticut, United States
Blue Grass Care Clinic
🇺🇸Lexington, Kentucky, United States
University of Kentucky Medical Center
🇺🇸Lexington, Kentucky, United States
University of Kentucky
🇺🇸Lexington, Kentucky, United States
Louisiana State University Health Sciences Center
🇺🇸New Orleans, Louisiana, United States
University Of Michigan Health Systems
🇺🇸Ann Arbor, Michigan, United States
Nemechek Health Renewal
🇺🇸Kansas City, Missouri, United States
Central Texas Clinical Research
🇺🇸Austin, Texas, United States
Wake Forest University Health Sciences
🇺🇸Winston-Salem, North Carolina, United States
Low Country Infectious Diseases, P.A.
🇺🇸Charleston, South Carolina, United States
Medical University of South Carolina
🇺🇸Charleston, South Carolina, United States